Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 3 Withdrawn 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 55 Decitabine 33 Azacitidine 30 Idarubicin 22 venetoclax 21 fludarabine 16 Cyclophosphamide 16 Granulocyte Colony-Stimulating Factor 15 Daunorubicin 12 Mitoxantrone 9 Etoposide 8 Cladribine 8 Busulfan 8 Aclarubicin 8 Homoharringtonine 7 Filgrastim 7 Peripheral Blood Stem Cell Transplantation 6 fludarabine phosphate 5 aclacinomycins 4 Tretinoin 4 Sorafenib 4 Radiotherapy 4 Polymerase Chain Reaction 4 Mycophenolic Acid 4 Lenalidomide 4 Gemtuzumab 4 Cyclosporine 4 Clofarabine 4 Arsenic Trioxide 4 sargramostim 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia, Myeloid, Acute × posaconazole × Clear all

NCT03796533 2022-02-24

Posa-Pk

Hospices Civils de Lyon

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡